Kintara Therapeutics Stock Quote KTRA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.1425

Bid

0.1402

Ask

0.1425

Volume

51,611,501

0.1356 Day's Range 0.195

0.081 52 Week Range 5.98

Market Cap

5.856M

Previous Close

0.158

Open

0.195

Last Trade

0.1425

Last Trade Time

Financial Volume

$ 8,209,449

VWAP

0.159062

Average Volume (3m)

14,359,220

Shares Outstanding

39,037,899

Dividend Yield

PE Ratio

-0.39

Earnings Per Share (EPS)

-0.38

Revenue

Net Profit

-15.02M

Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and ... Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs. The company is developing two late-stage, Phase 3-ready therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for GBM and REM-001 for CMBC. VAL-083 is a small-molecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers, including the central nervous system, ovarian, and other solid tumors. The company is also advancing its proprietary late stage photodynamic therapy (PDT) platform that holds promise as a localized cutaneous or visceral tumor treatment as well as in other potential indications. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kintara.com

Headquarters

Reno, Nevada, USA

Founded

1970

Kintara Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KTRA. The last closing price for Kintara Therapeutics was $0.16. Over the last year, Kintara Therapeutics shares have traded in a share price range of $ 0.081 to $ 5.98.

Kintara Therapeutics currently has 39,037,899 shares outstanding. The market capitalization of Kintara Therapeutics is $5.86 million. Kintara Therapeutics has a price to earnings ratio (PE ratio) of -0.39.

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer

Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer PR Newswire SAN DIEGO, Feb. 12, 2024 - 15-patient Open Label Study to...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.023	19.2468619247	0.1195	0.195	0.111	6883017	0.13820761	CS
4	0.0445	45.4081632653	0.098	0.24	0.0925	17385585	0.15363986	CS
12	0.0163	12.9160063391	0.1262	0.24	0.081	14359220	0.12544278	CS
26	-3.6875	-96.2793733681	3.83	4.48	0.081	9853584	0.14427673	CS
52	-2.8075	-95.1694915254	2.95	5.98	0.081	4976790	0.18405305	CS
156	-77.8575	-99.8173076923	78	142.5	0.081	2699553	10.4381058	CS
260	-60.3575	-99.7644628099	60.5	167.5	0.081	2320026	14.90774669	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M